Introduction

I
n recent years, health spending growth has exceeded economic growth in many countries. This is the result of an overall increased interest in health. 1 To control health spending, a diagnosis-related group (DRG) based payment programme was suggested as a health care system in the USA. Following the introduction of the DRG system in the USA, many countries have adopted it and modified it based on their individual needs. 2, 3 In Korea, average annual growth in health spending and health expenditures during 2000-12 increased faster than that of the Organisation for Economic Co-operation and Development (OECD) Asia region (Asia region: 4.6%, Korea: 7.5%). 1 The DRG system was introduced in 1997 as a way to control health spending and to improve health efficiency in Korea. The Korean-DRG system was based on the US Yale Refined DRG system. 4 The criteria for DRG were selected by evaluating the variation in medical expenditures that were similar clinically as well as similar in consumption of resources. Following the pilot programme, which lasted for several years, the DRG system was implemented for seven disease groups in 2002 through voluntary participation. Recently, the DRG system was implemented throughout the nation, resulting in changes for Korea's health care system. The implementation of the DRG system for hospitals and clinics became mandatory on 1 July 2012 and for general and tertiary hospitals on 1 July 2013. These changes in the payment mechanisms for hospitals care affected competition among hospitals 5, 6 primarily through hospital performance and quality of care. [7] [8] [9] [10] In response to the new payment system, hospitals adopted various cost-saving strategies and changed their medical health behaviour. In addition, changes in hospital performance differed according to degree of market competition. The differences in market competition affected hospital behaviour and led to differences in quality of care.
Previous studies suggest that introduction of the health care system influenced competition in the market. 11 Further studies on quality of care and market competition were conducted by many other researchers 12, 13 and concerns regarding the introduction of the DRG system and quality of care were noted. 14 In addition, other studies have found benefits to the DRG system, such as a reduction in healthcare costs and length of stay (LOS). 15, 16 In Korea, many studies have been conducted on the association between the quality of care and the DRG system. [17] [18] [19] However, few studies have been conducted after mandatory adoption of DRG system in Korea. In addition, hospitals in Korea have undergone dramatic changes within a few decades and studies on the effects of market competition are needed.
Thus, the purpose of this study is to examine the association between the effects of market competition and quality of care following the introduction of the DRG system in Korea. We use data on readmission within 30 days after discharge, number of outpatient visits and LOS to measure quality of care and changes in hospital behaviour.
Methods
Database and data collection
We used National Health Insurance (NHI) claim data collected during July 2011 to July 2014 for patients admitted to hospitals due to haemorrhoids (Korean DRG codes: G1020, G1040, G1050 and G1060). Each DRG code is subdivided by severity of complication and comorbidity. We included clinic in our study because more than 50% of patients were admitted to clinics. In Korea, clinics have operating rooms and facilities for inpatients. Additionally, we analysed data on readmission within 30 days after discharge, LOS and number of outpatient visits within 30 days of admission from 1742 hospitals. Our analysis included 821 912 hospitalizations.
Variables
The outcome variable used in this study is readmission within 30 days after discharge for haemorrhoids. We identified the patient's first hospitalization and discharge in the calendar year as the first index hospitalization and discharge. Next, we examined whether readmission occurred within 30 days after the first index day in the same hospital or another hospital. Furthermore, we matched the patient's primary diagnosis of the first hospitalization and that of the readmission and defined it as a readmission. LOS was measured using date of admission and date of discharge. We used a log transformation for LOS to reflect the original scale of the skewed data and to measure the relationship by estimating changes in the dependent variable in response to per cent changes in the explanatory variable (for further details, see Supplementary data 1). [20] [21] [22] [23] Number of outpatient visits was defined as visiting an outpatient clinic within 30 days before or after hospitalization, based on the day of admission or discharge, respectively.
We extracted patient-level data and matched hospital-level data for the hospital to which the patient had been admitted. Hospitallevel data included hospital type (tertiary hospital, general hospital, hospital or clinic), ownership status (private or public), teaching status (teaching or non-teaching), size (number of beds), case mix index and hospital location (urban or rural). Data on the introduction of the DRG system was classified by newly introduced organizations or continuously adopted organizations. Clinics and hospitals were required to implement the DRG system from 1 July 2012. Both general hospitals and tertiary hospitals were required to implement the DRG system from 1 July 2013. Newly introduced organizations were defined as hospitals that participated in the DRG system during the mandatory period, whereas hospitals that had previously voluntarily participated in the DRG system were classified as continuously adopted organizations. Human resources (doctors, nurses and pharmacists) were included to reflect differences in hospital scale. Patient-level data included patient ID, sex, age, patient clinical complexity level and year.
The Hirschmann-Herfindal Index (HHI) was used to reflect the degree of market competition. HHI was calculated using patient claim data from all hospitals using the following equation.
The HHI is the sum of squared market share of hospital under the defined market. Market share S i is calculated using the total discharged patients for haemorrhoid, i indicates each hospital and n is the total number of hospitals in a specific market area, meaning that high HHI indicates low market competition or hospital had a dominant effect in the market area. To measure the different effects of market competition, we categorized market competition as high, moderate or low using quartiles of HHI.
Statistical analysis
The distribution of each categorical variable was examined by an analysis of frequencies and percentages, and 2 tests were performed to examine associations with readmission within 30 days. Analysis of variance was also performed to compare the average values and standard deviations for continuous variables. Generalized estimating equation regression models were used to examine associations with readmission within 30 days after discharge and number of outpatient visits. Multi-level regression models were used to investigate the association between LOS and each variable (Null model ICC: 0.685, for further details, see Supplementary data 1). 24, 25 In addition, subgroup analyses were performed according to the introduction of the DRG system and type of hospital. All statistical analyses were performed using SAS statistical software version 9.3. P-values < 0.05 were considered indicative of statistically significant differences.
Results
The data used in this study consisted of 821 912 hospitalizations and 1742 hospitals. There were 10 727 (1.3%) cases of readmission within 30 days after discharge. The average LOS was the shortest in moderate competition areas, whereas low competition areas had the longest LOS as compared with other areas. Number of outpatient visits was highest in low competition areas and lowest in moderate competition areas (table 1) .
We used generalized estimating equation models to evaluate readmission within 30 days after discharge. Interestingly, the risk of readmission was higher in low competition areas [odds ratio (OR): 1.21, P < 0.0001] as compared with moderate competition areas. High competition areas had a lower risk of readmission (OR: 0.95, P-value: 0.0277) as compared with moderate competition areas. LOS was slightly (1%) higher in high competition areas as compared with moderate competition areas. Number of outpatient visits was higher in both high and low competition areas as compared with moderate competition areas (high competition areas-relative risk (RR): 1.11, P-value: 0.0011; low competition areas-RR: 1.06, P-value: 0.2485) (table 2) .
According to the subgroup analysis of the introduction of the DRG system, newly introduced organizations located in high and low competition areas had a high risk of readmission within 30 days that was not statistically significant. LOS was significantly decreased in high competition areas (2.7%, P: 0.0004). In the case of number of outpatient visits, low competition areas had a lower number of outpatient visits and high competition areas had a higher outpatient visits (high competition area-RR: 1.15; low competition area-RR: 0.98). Continuously adopted organizations that voluntarily implemented the DRG system showed trends similar to the main results. High competition areas presented a lower risk of readmission, a higher LOS, and a higher number of outpatient visits, all of which were statistically significant (readmission-OR: 0.90; LOS-1%; number of outpatient visits-RR: 1.09). In contrast with high competition areas, low competition areas had a higher risk of readmission within 30 days and a higher number of outpatient visits (readmission-OR: 1.24; number of outpatient visits-RR: 1.06). The subgroup analysis showed that clinics and hospitals displayed similar trends for each outcome variable. Readmission was higher in low competition areas, whereas lower in high competition areas. LOS increased by 0.64% to 1.50% in the high competition area. Number of outpatient visits was higher in both the high and low competition areas. Except for readmission, general and tertiary hospitals showed similar trends in LOS and outpatient visits. However, the impact on number of outpatient visits for general and tertiary hospitals were higher in the low and high competition areas; these findings were statistically significantly (table 3) .
Discussion
The introduction of a new payment system can affect a hospital's medical behaviour and may cause unexpected results according to the degree of market competition.
14 For example, hospitals located in high competition areas will make an effort to attract patients and hospitals located in low competition areas will focus on patient durability (i.e. continuous care). 26 The DRG system provides medical services for certain diseases according to a fixed amount, regardless of the type of hospital. Under the DRG system, patients can select a hospital without considering the burden of cost and will have the opportunity to choose their preferred hospital. In contrast, the hospital may change its existing medical services or medical behaviours.
Many previous studies have reported on the association between quality of care and market competition. Some studies have suggested that competition has a negative or unclear association with quality of care, 27, 28 whereas others have suggested that competition induces better quality of care or is, at least, not associated with adverse effects. 12, 29, 30 Although some studies show that competitive area has better quality of care, 9 other studies suggested that it might be associated with supplier induced demand in Korea. 31, 32 However, these studies did not measure other effects, such as spillover effects, under the DRG system. Furthermore, there have not been any studies conducted on the association between competition and quality of care in Korea after introduction of the DRG system. To investigate the changes in the Korean healthcare system following the introduction of the DRG system, we examined the association between market competition and quality of care.
In our study, hospitals located in high competition areas had a lower risk of readmission as compared with those in moderate competition areas. Because readmission within 30 days is suggested as an indicator of quality of care, hospitals in high competition areas made an effort to reduce readmission. 33, 34 To maintain quality of care, hospitals provided further clinical care in the hospitalization or outpatient clinic. It might induce to increasing of LOS and number of outpatient visits. Increasing number of outpatient would be considered as a spillover effect. To control readmission, hospitals in high competition area would be provided additional clinical care in outpatient clinic, it lead to unintended results of increasing outpatient visits. This scenario would be considered a spillover effect of the DRG system. In contrast, hospitals in low competition areas will not make significant efforts to improve quality of care because patients have few options for hospitals as compared with other competition areas.
Regarding the result of subgroup analysis by introduction of the DRG system, readmission was differed from the competitive status. Hospitals in high competition area that have recently adopted the DRG system will make an effort to reduce LOS for hospitalized patients. Under the DRG system, reimbursement differed by average LOS even though the amount was fixed. Hospital would be preferable to maintain the threshold of average LOS due to it was more beneficial. This may be connected with short LOS. In addition, postoperative care would be conducted in an outpatient clinic rather than requiring re-hospitalization; it might induce to increase in number of outpatient visits. This phenomenon might be observed during the introductory stages of the implementation of the DRG system; however, the results may be different after the settlement of the system. We found different results for readmission for the group of continuously adopted organizations. Hospitals in high competition areas will attempt to control quality of care, which might lead to a reduction in the rate of readmission within 30 days. Furthermore, to maintain quality of care, LOS increased slightly for postoperative care during hospitalization. On the contrary, outpatient care for postoperative care increased in order to reduce readmission. These results suggest that there are impacts of the implementation of the DRG system.
In low competition areas, there were no differences in trend for risk of readmission within 30 days based on the timing of the introduction of the DRG system. Because there were no changes in the quality of care in hospitals located in low competition areas, there may be an increased risk of readmission within 30 days regardless of timing of the introduction of the DRG system. In addition, number of outpatient visits was lower for newly adopted organization located in low competition areas. But, after the stabilization of the DRG system, these hospitals increased the number of outpatient visits and readmission. This is because that hospital can learn from their experiences with the DRG system and discover the options that will provide the highest profits.
The new payment system is expected to bring changes to the health system. However, the impact of the payment system should be considered together with the specific environment of the health system of each country. In Korea, the DRG system was implemented as an alternative to the fee-for-service strategy, which was different from the European countries that had adopted global budget systems. Thus, the effects of DRG system may be different for Korea. The DRG payment system in Korea created more profitability for hospitals because the reimbursement level under the DRG system was greater on average than that under the fee-for-service system. 4 This reduced the number of disputes regarding the mandatory adoption of the DRG system. However, many health providers still believe that the reimbursement level under the DRG system is too low, and this belief became predominant following the mandatory adoption of the DRG system. 4 Consequently, health care providers may attempt to compensate for any decrease in profit due to the DRG system by discharging patients earlier than expected (or needed) to potentially induce an increase in the use of other facilities or in outpatient visits. Spillover effect may appear through the increasing of outpatient visits.
In addition, the impact of introduction of DRG system was different by competitive status. Therefore, the expansion or development of a new reimbursement system must be implemented more carefully considering such differences. First, a suitable index for quality of care under the DRG system should be developed. Indicators for quality of care should be created for predictable readmission as well as for measuring actual changes in medical services. Second, the impact of the DRG system should be assessed over the long term to evaluate its impact on quality of care. Third, an appropriate incentive programme that is based on quality indicators is needed to introduce for improving quality of care in DRG system. Finally, it may be worthwhile to consider the introduction of new payment system as an alternative strategy to the DRG system, such as a bundled payment system that provides a fixed cost during a specific period and includes inpatient and outpatient health care services.
Our study has several limitations. First, we used claim data that did not measure certain characteristics of the patients, such as education level or income level, which could affect readmission. Second, our study included patients admitted for haemorrhoids; however, the results might vary for other DRG diseases. Third, we lacked an official definition of the hospital market in Korea; hence, our study relied on administrative districts as markets. Because our markets were defined as geographical areas, further studies will be required following the designation of official markets.
However, despite several limitations, our study has strengths. First, to the best of our knowledge, our study was the first to evaluate market competition and quality of care after the introduction of the DRG system in Korea. Second, we used NHI claim data and included a large sample of patients and hospitals regarding cases of haemorrhoids. Third, our study is helpful as a short-term evaluation of the introduction of the DRG system in Korea. Finally, our study examined changes in hospitals by market competition, which may provide insight to policymakers interested in the expansion of the DRG system in the future.
In conclusion, our study showed that the effects of the introduction of the DRG system differed by to degree of market competition. Generally, hospitals in high competition areas provided a high quality of care. However, the timing of introduction of DRG system affected quality of care, as we found different results following its implementation. Under the DRG system, a spillover effect was observed through the indirect indicator of quality of care irrespective of competitive status. Policymakers should consider two aspects for future payment systems-the inclusion of an alternative strategy as well as a new indicator for quality of care. In addition, a regular evaluation of the DRG system will be needed to improve quality of care and health efficiency.
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